Independent Director · BIOCRYST PHARMACEUTICALS INC (BCRX)

Chair, Audit Committee

Alan G. Levin director compensation at Biocryst (FY2025): $397K

Fiscal year 2025 director compensation for Alan G. Levin at BIOCRYST PHARMACEUTICALS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

BIOCRYST PHARMACEUTICALS Director Compensation Table · the one fiscal year held
In US dollars, as BIOCRYST PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$72,500$130,000$194,996—$397,496

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOCRYST PHARMACEUTICALS INC DEF 14A filed April 23, 2026, accession 0001628280-26-026822, and prior-year filings. Open the filing on EDGAR.

That is Alan G. Levin’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.

Saved. One email when Alan G. Levin’s next annual disclosure lands here, with the figure.

One email when Alan G. Levin’s next annual disclosure is on this page, with the figure. Nothing else is sent.

Get the BIOCRYST PHARMACEUTICALS Board Governance Report

$397,496 Alan G. Levin, FY2025 total director compensation

$499

The free page is the headline figures. The board report is director pay, board composition and committee fees assembled into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

BIOCRYST PHARMACEUTICALS pays directors a $45,000 cash retainer and $325,000 in 60% stock options and 40% RSUs.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the BIOCRYST PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
A. Machelle SandersIndependent Director$385,253
Amy E. McKee, M.DIndependent Director$389,996
Charles K. GayerDirector—
Jill C. Milne, Ph.DIndependent Director—
Jon P. StonehouseDirector—
Stephen J. AselageIndependent Director$33,475
Steven K. Galson, M.D., MPHIndependent Director$385,584
Steven R. FrankIndependent Director$396,489
Theresa M. HeggieIndependent Director$401,700
Vincent J. MilanoIndependent Director$403,695

The full BIOCRYST PHARMACEUTICALS compensation record

free company brief

This page is one director within BIOCRYST PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the BIOCRYST PHARMACEUTICALS proxy · each links to its own free brief

Track this executive's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat

A confirmation now and one email when Pro opens, and nothing else. Privacy

Order BCRX

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report